As of Thursday close, Novo Integrated Sciences Inc.’s (NASDAQ:NVOS) stock was down -$0.03, moving down -15.79 percent to $0.15. The average number of shares traded per day over the past five days has been 156,373,469 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0698 gain in that time frame. In the last twenty days, the average volume was 41,726,734, while in the previous 50 days, it was 18,991,949.
Since last month, NVOS stock rose 28.15%. Shares of the company fell to $0.0690 on 08/14/23, the lowest level in the past month. A 52-week high of $1.82 was reached on 01/09/23 after having rallying from a 52-week low of $0.07. Since the beginning of this year, NVOS’s stock price has dropped by -24.17% or -$0.0486, and marked a new high 2 times. However, the stock has declined by -91.60% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
The stock’s beta is -0.38. Besides these, the trailing price-to-sales (P/S) ratio of 19.91, the price-to-book (PB) ratio of 0.80.
Financial Health
In the recent quarter, Novo Integrated Sciences Inc.’s quick ratio stood at 0.50, while its current ratio was 0.60, showing that the company is not able to pay off its debt. Based on annual data, NVOS earned $4.8 million in gross profit and brought in $11.74 million in revenue.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. NVOS’s revenue rose 12.77% to $3.42 million during the quarter, while net income inched up to $3.29 million. During the quarter, the company generated -$0.69 million in EBITDA. The liabilities of Novo Integrated Sciences Inc. were 9.45 million at the end of its most recent quarter, and its total debt was $4.58 million. The value of shareholders’ equity is $148.43 million.
Technical Picture
This quick technical analysis looks at Novo Integrated Sciences Inc.’s (NVOS) price momentum. With a historical volatility rate of 370.67%, the RSI 9-day stood at 64.22% on 17 August.
With respect to its five-day moving average, the current Novo Integrated Sciences Inc. price is up by +84.40% percent or $0.0698. At present, NVOS shares trade +33.65% above its 20-day simple moving average and +18.77% percent above its 100-day simple moving average. However, the stock is currently trading approximately +3.74% above its SMA50 and -44.59% below its SMA200.
Stochastic coefficient K was 58.62% and Stochastic coefficient D was 43.05%, while ATR was 0.0319. Given the Stochastic reading of 46.16% for the 14-day period, the RSI (14) reading has been calculated as 60.96%. As of today, the MACD Oscillator reading stands at 0.0446, while the 14-day reading stands at 0.0441.
Analyst Ratings
Novo Integrated Sciences Inc. (NVOS) has been rated – by analysts. According to 0 brokerage firms, NVOS is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Novo Integrated Sciences Inc. stock as buy, with 0 recommending it as overweight.
